Raymond James Financial
CDNA icon

Raymond James Financial’s CareDx CDNA Stock Holding History

Raymond James Financial’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.29M Sell
150,478
-6,005
-4% -$131K ﹤0.01% 2862
2026
Q1 		$2.72M Sell
156,483
-5,508
-3% -$104K ﹤0.01% 3101
2025
Q4 		$3.05M Sell
161,991
-4,792
-3% -$80.3K ﹤0.01% 2918
2025
Q3 		$2.43M Sell
166,783
-13,836
-8% -$197K ﹤0.01% 3020
2025
Q2 		$3.53M Buy
180,619
+12,742
+8% +$226K ﹤0.01% 2626
2025
Q1 		$2.98M Sell
167,877
-4,682
-3% -$101K ﹤0.01% 2692
2024
Q4 		$3.69M Buy
+172,559
New +$4.2M ﹤0.01% 2522

Other funds holding CDNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Raymond James Financial's CDNA Position: Q2 2026 in Review

Raymond James Financial reduced its CareDx (CDNA) stake by 3.8% in Q2 2026, selling an estimated $131K and leaving 150,478 shares worth $4.29M. The position accounts for ﹤0.01% of the portfolio, ranked #2862.

Raymond James Financial first reported a position in CDNA in Q4 2024 and has held it in 7 quarters since. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Raymond James Financial held 150,478 shares of CareDx worth $4.29M as of Q2 2026.
  • Raymond James Financial sold 6,005 CareDx shares in Q2 2026, an estimated $131K.
  • CareDx made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #2862 holding.
  • Raymond James Financial first reported a position in CareDx in Q4 2024 and has held it in 7 quarters since.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.